Ropes & Gray advised EQRx in a partnership to leverage Germany-based Evotec’s data-driven integrated drug discovery and development platform across different drug modalities and therapeutic areas in oncology and immunology. The transaction was announced on November 18.
Under the agreement, EQRx and Evotec will collaborate on drug discovery and pre-clinical development, while EQRx will be responsible for clinical development, regulatory and commercialization efforts.
The Ropes & Gray team was led by life sciences partner Abigail Gregor (Boston).
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.